UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...
FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...
As filed with the Securities and Exchange Commission on December 2, 2020 Registration No. 333-232351 Registration...
December 2, 2020 BY EDGAR TRANSMISSION Securities and Exchange Commission 100 F Street, NE Washington, DC...
BIOSPECIFICS TECHNOLOGIES CORP false 0000875622 --12-31 0000875622 2020-12-02 2020-12-02 UNITED...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals PR Newswire WILMINGTON, Del., Dec. 2, 2020 WILMINGTON, Del., Dec. 2...
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.